This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Plaintiffs ask US Supreme Court to review antitrust case against Merck over mumps vaccines

( July 10, 2025, 22:31 GMT | Official Statement) -- MLex Summary: Plaintiffs accusing Merck of unlawfully extending its monopoly over mumps vaccines by making false drug-label claims asked the US Supreme Court to review their case and rule that those who intentionally and successfully deceive the government in adjudicative proceedings are not immune from antitrust liability. “This case offers a golden opportunity to resolve the split, and clear up the longstanding confusion, over Noerr-Pennington’s reach. The Third Circuit’s decision turned on its application of the doctrine, and, as its recitation of the facts make clear, its judgment rises and falls with the answer to the question presented,” they said.See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents